Protocol summary and statistical analysis plan for the randomized trial of early detection of clinically significant prostate cancer (ProScreen) https://www.medrxiv.org/content/10.1101/2023.05.09.23289669
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.